Marcus Ineson - Fractional Commercial Director / COO / Clinical Director

EXECUTIVE POSITIONING

I work with founder-led and investor-backed MedTech, Pharma and healthcare SMEs (£5m–£50m turnover) to accelerate commercial velocity, stabilise clinical operations and prepare for high-value exit or scale.

25+ years building and transforming revenue-led and clinically regulated organisations across the UK, Europe and international markets

Specialist in:

  • Commercial-Clinical Bridge building: Driving commercial success in clinical and highly regulated sectors.

  • Start-up & Scale-up Execution: Taking novel medical devices from early concept to international market entry.

  • Turnaround & Profitability: Rapidly stabilising failing business units and improving EBITDA.

  • AI-Augmented Operations: Utilising AI early but responsibly to accelerate performance, maximise the use of resources and compliance.

  • NHS Market Access: Expert navigation of UK procurement, tenders and clinical governance frameworks.

  • Exit & Investment Readiness: Professionalising governance and operational discipline for Series A–C or acquisition.

WHAT I DO FOR FOUNDERS / LEADERS

Revenue Acceleration

  • Direct Execution: Personally leading functions or projects to drive immediate revenue and growth.

  • Healthcare organisation establishment or scaling: Creating the operations and governance framework to allow the safe abd effective commencement and expansion of clinical services.

  • Sales Force Effectiveness: Implementing productivity metrics and behaviour-based career pathways to lift team output.

  • Market Expansion: Designing and executing UK and international go-to-market strategies for novel MedTech.

Cost & Margin Expansion

  • Operational Turnaround: Identification and turnaround of services and contracts to return organisations to profitability.

  • Digital Integration: Project managing of digital backbones such as CRMs and Electronic Health Records (EHR) to reduce overhead and increase efficacy.

  • Compliance Automation: Using AI and digital tools to automate routine tasks while remaining compliant with regulations (CQC, MHRA, ABPI).

Exit / Scale Preparation

  • Governance & Risk: Stabilising the business for due diligence by embedding robust organisational and clinical governance frameworks.

  • Strategic Planning: Delivering three-year strategic and operational plans that align with investor expectations.

  • Leadership Development: Restructuring business units to increase capability while maintaining high employee engagement.

BOARD & GOVERNANCE / CREDENTIALS

  • GM/Marketing Director/CMO-GBUK Enteral & Healthcare, NGPOD Global

  • Director of Operational Excellence/Director fo Clinical Services: Bionical Health, Uniphar (Outico).

  • Registered Manager: Uniphar (Outico)

  • Registered Nurse (RGN)

  • Governance Specialist: Expert in CQC, MHRA and ABPI regulatory compliance

 

I operate on a fractional basis or through defined transformation mandates and project scopes.

SELECTED IMPACT

  • £1.6m P&L Swing: Turned a failing business unit from a -£1.2 million loss to a +£400k profit in 10 months.

  • £20m+ Annual Revenue Growth: Delivered 16 new NHS contract wins from competitors worth £20m/year with zero tender losses.

  • Rapid Market Entry: Launched a novel medical device into international markets during the pandemic with no budget.

  • Efficiency Gains: Increased clinical productive time from 45% to 68% within 9 months.

  • Large-Scale Leadership: Led a UK-wide clinical team of 100+ staff managing 80+ NHS contracts and a £4.8m budget.

  • Compliance Excellence: Secured multiple successful CQC/RQIA/SI registrations for private healthcare providers and improved inspection ratings, adding value to organisations.

CURRENT & RECENT ENGAGEMENTS

M&JI Ltd (govENHANCE® & Nascentis®) – Co-Founder. Strategic commercial and clinical governance leadership for MedTech and healthcare SMEs.

NGPOD Global Ltd – Chief Marketing Officer. Strategic sales and marketing oversight for a start-up medical device company.

Uniphar Ltd – Interim Director Patient Services. Restructured healthcare delivery businesses and integrated digital acquisitions.

Bionical Health Outcomes – Interim Director of Operational Excellence. Led division mergers and business unit turnarounds.

Available for:

  • Fractional Commercial Director / COO / Clinical Director mandates.

  • Growth & EBITDA Transformation projects.

  • Advisory / Investor Support for MedTech exit and scale planning.

Work With Us